Literature DB >> 33649537

Premalignant pancreatic cells seed stealth metastasis in distant organs in mice.

Junpei Yamaguchi1, Toshio Kokuryo2, Yukihiro Yokoyama2, Tomoki Ebata2, Yosuke Ochiai2, Masato Nagino2.   

Abstract

Recent findings suggest that the dissemination of tumor cells occurs at the early stage of breast and pancreatic carcinogenesis, which is known as early dissemination. The evidence of early dissemination has been demonstrated predominantly in the bloodstream and bone marrow; however, limited evidence has revealed the existence and behavior of disseminated cells in distant organs. Here, we show that premalignant pancreatic cells seed distant stealth metastasis that eventually develops into manifest metastasis. By analyzing lineage-labeled pancreatic cancer mouse models (KPCT/TFF1KO; Pdx1-Cre/LSL-KRASG12D/LSL-p53R172H/LSL-tdTomato/TFF1KO), we found that premalignant pancreatic cells, rather than mature malignant cells, were prone to enter the bloodstream and reside in the bone marrow, liver, and lung. While these metastatic cells exhibited the characteristics of the cells of host organs and did not behave as malignant cells, they underwent malignant transformation and formed distinct tumors. Surprisingly, the manifestation of distant metastasis occurred even before tumor development in the primary site. Our data revealed that disseminated premalignant cells reside stealthily in distant organs and evolve in parallel with the progression of the primary tumor. These observations suggest that we must rebuild a therapeutic strategy for metastatic pancreatic cancer.

Entities:  

Year:  2021        PMID: 33649537     DOI: 10.1038/s41388-021-01706-8

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

Review 1.  Circulating tumor cells: biology and clinical significance.

Authors:  Danfeng Lin; Lesang Shen; Meng Luo; Kun Zhang; Jinfan Li; Qi Yang; Fangfang Zhu; Dan Zhou; Shu Zheng; Yiding Chen; Jiaojiao Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-11-22

2.  Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients' Blood.

Authors:  Paul Friedrich Geus; Felix Hehnen; Sophia Krakowski; Klaus Lücke; Dave S B Hoon; Nikolaj Frost; Ulrich Kertzscher; Gabi Wendt
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.